Editorial: bacterial gut symbionts as live biotherapeutic agents in irritable bowel syndrome-a rosy future despite potential long-term safety concerns

Aliment Pharmacol Ther. 2023 Feb;57(3):345-346. doi: 10.1111/apt.17332.

Authors

Giacomo Mantegazza¹, Giorgio Gargari¹, Simone Guglielmetti¹

Affiliation

¹ Division of Food Microbiology and Bioprocesses, Department of Food, Environment, and Nutritional Sciences, University of Milan, Milan, Italy.

PMID: 36641795
DOI: 10.1111/apt.17332

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Irritable Bowel Syndrome* / drug therapy
Irritable Bowel Syndrome* / microbiology